Presentation
5 March 2021 Raman-guided subcellular pharmaco-metabolomics for metastatic melanoma
Author Affiliations +
Abstract
We utilized Raman spectro-microscopy to non-invasively probe metabomics within single live cells, aiming to identify druggable metabolic susceptibilities from a series of patient-derived BRAF mutant melanoma cell lines. Each cell line represents a phenotype with different characteristic level of de-differentiation and BRAFi (BRAF inhibitor) resistance. First, with single-cell Raman spectroscopy and stimulated Raman scattering (SRS) microscopy, followed by transcriptomics analysis, we identified lipid processes as major metabolic functional difference between different phenotypes. We then utilized hyperspectral-SRS imaging on intracellular single organelles to identify a previously unknown susceptibility of lipid desaturation within de-differentiated cell lines. Drugging this target leads to cellular apoptosis accompanied by phase separated intracellular domains. The integration of subcellular Raman spectro-microscopy with lipidomics and transcriptomics suggests highly heterogenous metabolic responses and possible lipid regulatory mechanisms underlying this pharmacological treatment. Our method should provide a general approach in spatially-resolved single cell metabolomics studies.
Conference Presentation
© (2021) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Jiajun Du and Lu Wei "Raman-guided subcellular pharmaco-metabolomics for metastatic melanoma", Proc. SPIE 11656, Advanced Chemical Microscopy for Life Science and Translational Medicine 2021, 116561G (5 March 2021); https://doi.org/10.1117/12.2576833
Advertisement
Advertisement
KEYWORDS
Melanoma

Raman spectroscopy

Cell death

Hyperspectral imaging

Microscopy

Raman scattering

Resistance

Back to Top